352 results on '"Echizen, Hirotoshi"'
Search Results
2. Correction: Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores
3. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery
4. Vancomycin Pharmacokinetics in Patients with Advanced Cancer Near End of Life
5. Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life
6. Analysis of the Association of Administration of various glucocorticoids with development of acute pancreatitis using US Food and Drug Administration adverse event reporting system (FAERS)
7. Simultaneous determination of N1-methylnicotinamide, l-carnitine, and creatinine in human plasma and urine by liquid chromatography with mass spectrometry for assessing the activities of multiple renal cationic transporters
8. Causal relationship between acute pancreatitis and methylprednisolone pulse therapy for fulminant autoimmune hepatitis: a case report and review of literature
9. Developmental changes of fluconazole clearance in neonates and infants in relation to ontogeny of glomerular filtration rate: literature review and data analysis
10. The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
11. Analysis of Information on Drug Adverse Reactions Using U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
12. Is Triamterene an Anti-Aldosterone Drug? — Letter from the Editor
13. Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally)
14. Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 1, Drugs Administered Intravenously)
15. Inter-Individual Differences in Baseline Coagulation Activities and Their Implications for International Normalized Ratio Control During Warfarin Initiation Therapy
16. Clinically Significant Drug Interactions with Antacids: An Update
17. Drug-Drug Interaction Profiles of Proton Pump Inhibitors
18. Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias
19. In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease
20. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery
21. Pharmacogenetics of Warfarin Elimination and its Clinical Implications
22. Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis
23. Serum Digoxin Concentrations and Outcomes in Patients with Heart Failure and Atrial Fibrillation: A Single-Center Observational Study
24. Catecholamine concentrations in biopsied gastroduodenal tissue specimens of patients with duodenal ulcer
25. Dopaminergic control of gastric mucosal blood flow in humans: A study with endoscopic laser doppler flowmetry coupled with gastric submucosal drug injection
26. Concise synthesis of the major metabolite M8 from ticagrelor and simultaneous determination of ticagrelor and M8 by a novel LC/MS method.
27. CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: Similarities yet differences
28. Clinical Pharmacokinetics of Famotidine
29. Pharmacokinetic Profile of a New Nonsteroidal Anti-Inflammatory Agent, CN-100, in Humans
30. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients
31. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients
32. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6β-hydroxycortisol
33. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children
34. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone
35. Detection of Signals of Convulsion-inducing Effect for Fluoroquinolone Antibiotics Alone and with Co-administration of Nonsteroidal Anti-inflammatory Drugs in Association with Aging Using Japanese Adverse Drug Event Reporting Database
36. A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin
37. Possible Drug Interaction between Oxycodone and Erythromycin: A Case Report and Analyses of Spontaneous Reporting Systems of Adverse Drug Reactions
38. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery
39. Effect of cigarette smoking on the pharmacokinetics of warfarin.: 28.
40. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes
41. Effect of gender on the pharmacokinetics of warfarin.: 9.
42. Effects of age and weight on the pharmacokinetics of warfarin.: 10.
43. Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life
44. Evaluation of a pharmacokinetic-pharmacodynamic model for hypouricaemic effects of febuxostat using datasets obtained from real-world patients
45. Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds
46. Induration at Injection or Infusion Site May Reduce Bioavailability of Parenteral Phenobarbital Administration
47. Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases
48. Impact of Pharmacists’ audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective study
49. Consequences of Different Corticosteroids on Serum Potassium and Prostate-Specific Antigen in Patients Receiving Abiraterone for Castration-Resistant Prostate Cancer: A Retrospective Observational Study
50. Correlations between the enantio- and regio-selective metabolisms of warfarin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.